These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22498679)

  • 21. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition.
    Chambers MS; Atack JR; Broughton HB; Collinson N; Cook S; Dawson GR; Hobbs SC; Marshall G; Maubach KA; Pillai GV; Reeve AJ; MacLeod AM
    J Med Chem; 2003 May; 46(11):2227-40. PubMed ID: 12747794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world navigation in amnestic mild cognitive impairment: The relation to visuospatial memory and volume of hippocampal subregions.
    Peter J; Sandkamp R; Minkova L; Schumacher LV; Kaller CP; Abdulkadir A; Klöppel S
    Neuropsychologia; 2018 Jan; 109():86-94. PubMed ID: 29237555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    Xie B; Liu Z; Jiang L; Liu W; Song M; Zhang Q; Zhang R; Cui D; Wang X; Xu S
    J Alzheimers Dis; 2017; 55(2):509-520. PubMed ID: 27662297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Awareness of olfactory deficits in healthy aging, amnestic mild cognitive impairment and Alzheimer's disease.
    Bahar-Fuchs A; Moss S; Rowe C; Savage G
    Int Psychogeriatr; 2011 Sep; 23(7):1097-106. PubMed ID: 21251352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic--comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study.
    Pusswald G; Moser D; Gleiss A; Janzek-Hawlat S; Auff E; Dal-Bianco P; Lehrner J
    Alzheimers Dement; 2013 Jul; 9(4):366-76. PubMed ID: 23164551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer's Disease Patients.
    Wams EJ; Wilcock GK; Foster RG; Wulff K
    Curr Alzheimer Res; 2017; 14(10):1030-1041. PubMed ID: 28545363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal GABA
    Neugebauer NM; Miyauchi M; Sato T; Tadano J; Akal H; Ardehali H; Meltzer HY
    Behav Brain Res; 2018 Apr; 342():11-18. PubMed ID: 29289597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors underlying cognitive decline in old age and Alzheimer's disease: the role of the hippocampus.
    Jaroudi W; Garami J; Garrido S; Hornberger M; Keri S; Moustafa AA
    Rev Neurosci; 2017 Oct; 28(7):705-714. PubMed ID: 28422707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer's disease and amnestic mild cognitive impairment: a systematic review and meta-analysis.
    Liu J; Wang LN; Jia JP
    Drugs Aging; 2015 Jan; 32(1):57-65. PubMed ID: 25504005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated hippocampal subfield segmentation in amnestic mild cognitive impairments.
    Lim HK; Hong SC; Jung WS; Ahn KJ; Won WY; Hahn C; Kim IS; Lee CU
    Dement Geriatr Cogn Disord; 2012; 33(5):327-33. PubMed ID: 22759884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heightened cortical excitability in aged rodents with memory impairment.
    Haberman RP; Koh MT; Gallagher M
    Neurobiol Aging; 2017 Jun; 54():144-151. PubMed ID: 28104309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
    Mah L; Binns MA; Steffens DC;
    Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prediction of conversion from amnestic mild cognitive impairment to Alzheimer's disease using proton magnetic resonance spectroscopy].
    Watanabe T; Shiino A; Akiguchi I
    Rinsho Shinkeigaku; 2015; 55(10):709-15. PubMed ID: 26369373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative Emotional Verbal Memory Biases in Mild Cognitive Impairment and Late-Onset Depression.
    Mah L; Anderson ND; Verhoeff NPLG; Pollock BG
    Am J Geriatr Psychiatry; 2017 Oct; 25(10):1160-1170. PubMed ID: 28595749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).
    Marra C; Gainotti G; Fadda L; Perri R; Lacidogna G; Scaricamazza E; Piccininni C; Quaranta D
    J Alzheimers Dis; 2016; 50(1):61-70. PubMed ID: 26639965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6,7-Dihydro-2-benzothiophen-4(5H)-ones: a novel class of GABA-A alpha5 receptor inverse agonists.
    Chambers MS; Atack JR; Bromidge FA; Broughton HB; Cook S; Dawson GR; Hobbs SC; Maubach KA; Reeve AJ; Seabrook GR; Wafford K; MacLeod AM
    J Med Chem; 2002 Mar; 45(6):1176-9. PubMed ID: 11881985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.